...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Wow…

Sep 23, 2024 10:38AM

Zen was looking bright. Now, Don's going double or nothing with RVX and using Zenith to cover the bet.


Sep 23, 2024 10:19PM
1
Sep 24, 2024 07:07AM
1
Sep 24, 2024 10:07AM
1
Sep 24, 2024 01:35PM

Sep 25, 2024 12:10PM
4
Sep 25, 2024 01:18PM
Share
New Message
Please login to post a reply